Ad-hoc Announcements 2010
Here you find Ad-hoc messages of year 2010.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
|October 31, 2010|
Bayer AG: Phase III ROCKET AF Study of Rivaroxaban meets its primary efficacy endpoint with Comparable Safety vs. Warfarin
collect (41 KB)|
|August 4, 2010|
Bayer AG: Rivaroxaban Meets Primary Endpoint in Long-Term Phase III EINSTEIN-DVT Study
collect (37 KB)|
Investor News issued in year 2010 can be found here.
Publications of the previous years are offered in the Archive Overview.